Resources

Learn how StudyTeam exceeded Sanofi's expectations when it came to measuring success by how useful it was for both sites and the sponsor.

Learn how Amgen increased patients enrolled per site, per month by 20 percent across its global portfolio.

Learn why 93% of Merck’s sites that choose StudyTeam used it again on subsequent Merck studies

Learn how Amgen increased patients enrolled per site, per month by 20 percent across its global portfolio.

Learn how by using site-focused strategy and technology, Amgen was able to expedite enrollment on a trial during a global pandemic.

Learn how Amgen increased patients enrolled per site, per month by 20 percent across its global portfolio.

Learn how a global Sponsor eliminates site burden, while gaining earlier visibility into site performance and pre-screening data.

Learn how Amgen increased patients enrolled per site, per month by 20 percent across its global portfolio.

Learn how sites that used StudyTeam™ were able to enroll 41% more patients in a Phase 3 lung cancer study.

Learn how Amgen increased patients enrolled per site, per month by 20 percent across its global portfolio.

Learn how the Sponsor knew, with confidence, which protocol amendments would accelerate enrollment.

Learn how Amgen increased patients enrolled per site, per month by 20 percent across its global portfolio.

Learn how StudyTeam provided an advantage in a competitive therapeutic area and increased the enrollment rate 215%.

Learn how Amgen increased patients enrolled per site, per month by 20 percent across its global portfolio.

Learn how ECIR replaced its multiple tracking systems with StudyTeam™ to share enrollment progress with all of its sponsors.

Learn how Amgen increased patients enrolled per site, per month by 20 percent across its global portfolio.

Learn how Amgen increased patients enrolled per site, per month by 20 percent across its global portfolio.

Learn how Amgen increased patients enrolled per site, per month by 20 percent across its global portfolio.

Learn how we helped a large global sponsor gain deep insight into the ROI of their recruitment tactics.

Learn how Reify and StudyTeam helped a global top-20 sponsor complete enrollment for a difficult Rare Disease trial a month ahead of schedule.

In this case study, learn how The Head of Oncology and her Clinical Operations team were able to overcome  challenges by deploying StudyTeam globally.

Join SCRS and Reify Health to learn how the GTO team at Merck is using data and technology to reduce site burden related to oncology trial enrollment and visit management so that research staff can focus on their work with patients.

Discover how to track trial enrollment status in real time, measure effectiveness of enrollment sources, ensure operational continuity during turnover, and standardize procedures for everyone on your team.

Learn how Sanofi is investing in innovation to support sites to supercharge their ability to manage enrollment.

Our experts will cover everything you need to know to propel patients toward enrollment in StudyTeam, including how to import patients in bulk, create custom labels, and schedule tasks in advance.

Learn how to see detailed reports to analyze your recruitment sources, track each potential participant’s path toward enrollment, and measure your overall progress for enrollment goals.

Reify Health's CEO Ralph Passarella and Amgen's Riddhi Chana discuss how through proactive planning and rapid decision-making Amgen accelerated patient enrollment during a pandemic .

Learn how to best manage all your trials with key StudyTeam features including creating research indications, easily searching your eligible patient population and adding patients from one trial to the next.

Rebecca Goldfaden from East Coast Institute for Research discusses how clinical trial sites can partner with sponsors to drive more efficient enrollment.

StudyTeam gives trial teams insight into how enrollment affects candidates across various racial and ethnic backgrounds.

StudyTeam, the patient enrollment platform for Oncology, moves pre-screening, I/E criteria tracking, and patient visit scheduling into a simple, clean, and searchable digital platform.

Trusted by the largest global biopharmaceutical companies to accelerate clinical trial enrollment.

Minimize lost referrals with SudyTeam's Referral Partner Interface (RPI) API. Automatically imports identified patient candidates directly from a recruitment vendor into StudyTeam.

Simple patient recruitment and enrollment, so you can eliminate redundant tasks and get back to the work that matters most: helping patients.

Simple patient recruitment and enrollment to keep your teams connected, monitor site recruitment from anywhere, and gain complete visibility across all of your sites.

Manage all your appointments and visits in one place with StudyTeam for Sites Visit Management! If you have a visit schedule, you can calculate your visit windows and track and schedule your protocol visits from the same place.

At ACRP 2022 in Orlando, Merck’s Samantha Birtel, global trial optimization senior scientist, shared Merck’s strategy to reduce site burden alongside Reify Health CEO Ralph Passarella.

In a panel discussion at SCOPE, we spoke with Lilly's Natalie Cheung Rotelli Seagen’s Neha Shah Londoño, about how the largest sponsor companies use new insights to create strategies that improve diversity across their trials.

As we mentioned, one third of eligible study participants ultimately fail to enroll. So, what goes wrong, and what can we do to improve the experience for subjects and staff alike?

Small considerations in managing top-of-funnel subject recruitment can make big differences for clinical trial performance.

While the industry spends more than $44 billion on clinical trials, 90% of potential patients are lost before enrollment. This signals a huge opportunity to drive more effective processes.

Screening potential clinical trial participants for health-related and demographic eligibility is a core foundation for success in trial enrollment.

Below we outline five potential issues to watch for in the first 90 days of a trial and describe how an established partnership between sites and sponsors can make these stumbling blocks easy to identify.

AstraZeneca, one of the world’s leading biopharmaceutical companies, selected StudyTeam to accelerate clinical development across its breast cancer investigational therapy portfolio.

Many sponsors want to improve the efficiency of their pre-screening and enrollment funnel. The challenge? Staying on top of clinical trial enrollment trends without burdening sites with more data entry or endless check-in calls.

The proprietary technology delivers patient referrals directly to the StudyTeam™ platform, empowering sites, sponsors, and recruitment vendors to collaborate simultaneously.

AstraZeneca will use Reify Health’s StudyTeam™ platform to accelerate clinical development, alleviate burden on research sites, and improve patient matching for global clinical trial enrollment.

We spoke with Natalie Marlen, a clinical research coordinator, about how she uses StudyTeam to save a day’s worth of work every week.

We sat down with Tyler Whitfield, a clinical research coordinator, to discuss how he manages the challenges of recruiting patients for clinical trials.

Reify Health expands StudyTeam to more than 100 countries and 2,700 clinical research sites.

Top sponsor deploys enrollment performance management platform to collaborate better with sites and enroll more effectively.

Series B round, led by Battery Ventures, will fuel growth of Reify's team and enhancements to StudyTeam platform.

Quick answers to frequently asked questions about our site offerings

Quick answers to frequently asked questions about our sponsor offerings

Curious how StudyTeam works? Reach out to schedule a demo today.

Need a refresher on StudyTeam? Our Customer Success team is glad to help.